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ABSTRACT
Objective: The objective of the present review is to
evaluate multicomponent/complex primary care (PC)
interventions for their effectiveness in continuous
smoking abstinence by adult smokers.
Design: A systematic review of randomised and non-
randomised controlled trials was undertaken.
Eligibility criteria for included studies: Selected
studies met the following criteria: evaluated effects of a
multicomponent/complex intervention (with 2 or more
intervention components) in achieving at least 6-month
abstinence in adult smokers who visited a PC,
biochemical confirmation of abstinence, intention-to-
treat analysis and results published in English/Spanish.
Methods: We followed PRISMA statement to report
the review. We searched the following data sources:
MEDLINE, Web of Science, Scopus (from inception to
February 2014), 3 key journals and a tobacco research
bulletin. The Scottish Intercollegiate Guidelines
Network checklists were used to evaluate
methodological quality. Data selection, evaluation and
extraction were done independently, using a paired
review approach. Owing to the heterogeneity of
interventions in the studies included, a meta-analysis
was not conducted.
Results: Of 1147 references identified, 9 studies were
selected (10 204 participants, up to 48 months of
follow-up, acceptable methodological quality).
Methodologies used were mainly individual or group
sessions, telephone conversations, brochures or quit-
smoking kits, medications and economic incentives for
doctors and no-cost medications for smokers. Complex
interventions achieved long-term continuous
abstinence ranging from 7% to 40%. Behavioural
interventions were effective and had a dose–response
effect. Both nicotine replacement and bupropion
therapy were safe and effective, with no observed
differences.
Conclusions: Multicomponent/complex interventions
in PC are effective and safe, appearing to achieve
greater long-term continuous smoking cessation than
usual care and counselling alone. Selected studies
were heterogeneous and some had significant losses
to follow-up. Our results show that smoking
interventions should include more than one component
and a strong follow-up of the patient to maximise
results.
BACKGROUND
Tobacco use continues to be the primary
cause of premature and overall mortality
worldwide,1 and treating the smoker is con-
sidered the ‘gold standard’ for the preven-
tion of chronic diseases.2 3 Healthcare
interventions are low cost in relation to the
gains achieved in quality and years of life.
From the public health point of view, the
results obtained may constitute the most cost-
effective means of improving the health of a
population.3–6 Smoking cessation interven-
tions carried out by health professionals have
been shown to increase abstinence rates.7–10
A minimum of smoking cessation counsel-
ling achieves an average of 5% cessation in
the general population per year;11 if com-
bined with intensive follow-up, this rate can
exceed 20%.12 13 When health professionals
offer assistance and support to break the
Strengths and limitations of this study
▪ Our systematic review shows that multicompo-
nent primary care interventions yield feasible,
effective, safe smoking cessation.
▪ Multiple component primary care interventions
best achieve long-term continuous abstinence.
▪ Multiple component strategies should include
setting a ‘D-day’ and drug therapies.
▪ Despite the rather strict inclusion criteria of the
present review, we found quite high heterogen-
eity in the results.
▪ Most essential components of the interventions
studied are not clearly established.
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habit, the likelihood of smoking cessation increases; fur-
thermore, this effect increases with the frequency and
duration of the interventions. In general, the proportion
of abstention increases with the intensity of the interven-
tion, the time spent, and the number and diversity of
contacts, including follow-up visits.12 On the other hand,
various systematic reviews and meta-analyses have shown
the utility of applying treatments with demonstrated
efﬁcacy.5 14 15
Interventions undertaken to promote smoking cessa-
tion, as well as other healthy behaviours, imply a wide
spectrum of complexity, due to numerous factors: (1)
the number and difﬁculty of the behaviours required of
participants, (2) the diverse types of professionals who
apply the intervention, (3) the existence of diverse, sep-
arate components that can act independently of and
interact with each other, (4) numerous variables with
diverse degrees of difﬁculty in their measurement, (5)
number and variability of outcomes, (6) changeable and
dynamic environments, and (7) the need for ﬂexibility
and adjustment of the interventions. This complexity
exerts a deep inﬂuence on the design of these interven-
tions, and the methodology, the measurements, the ana-
lysis and the results of these initiatives.16–18 In addition
to dissemination in scientiﬁc journals, these interven-
tions should be adapted to different settings and feasible
to implement.19 According to Grandes et al20, multicom-
ponent interventions are becoming more frequent, and
offer a promising new alternative in improving lifestyle
behaviours such as smoking cessation. Systematic reviews
that assemble scientiﬁc analysis on the efﬁciency of the
simple interventions are abundant; in contrast, the syn-
theses of the results of more complex interventions are
scarce, although lately they have been attracting great
interest.16 21 22
A ‘complex intervention’ is quite hard to deﬁne pre-
cisely and can sometimes be difﬁcult to distinguish from
a simple one; moreover, we have not found a clear deﬁn-
ition for this term.16 23 Complexity can be explained for
several different factors.18 We understand the term
‘complex intervention’ as those interventions with at
least two interacting components, such as procedures
(email tracking, for instance), behaviours (individual or
groupal interventions, for instance) or products
(medicines).16 21
The purpose of the present paper is to undertake a
systematic review focused on multicomponent interven-
tions, with the aim to offer a tool that could be useful
both to researchers and general practitioners in the
primary care setting. The speciﬁc objective of this study
is to determine the effectiveness of these interventions
in achieving continuous tobacco abstinence in smokers
aged 18 or older in the primary care setting. In order to
make the ﬁndings more practical and applicable, our
search strategy was focused on primary care setting.
Primary care is the most adequate and important setting
to implement interventions, to help smokers quit,
because most smokers visit their primary care
professionals at least once a year5 24 25 and is the health-
care level that can systematically integrate the method-
ologies for health promotion and disease promotion.
METHODS
The Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) statement was used as a
guide for reporting this review.26
Eligibility criteria
Articles included in this review met the Population,
Intervention, Comparison, Outcome (PICO) criteria
contained in WHO guidelines. Selected studies met the
following criteria: evaluated the effects of interventions
with at least two interacting components in individuals
older than 18 years who smoke any quantity of tobacco
and receive primary care. Smoking cessation was consid-
ered by achieving at least 6 months of continuous
smoking abstinence, veriﬁed biochemically. The deﬁn-
ition of continuous smoking abstinence was based on
that proposed by Hughes et al27 in 2003: a period of
total abstinence between a quit date and a follow-up
evaluation. We selected randomised controlled trials
(RCT) or non-RCTs, published in English or Spanish,
which included interventions with at least two compo-
nents, designed to help patients stop smoking and took
an intention-to-treat (ITT) approach. Studies were
excluded that were carried out only in adolescents
(<18 years old), did not report continuous abstinence
(≥6 months), were not carried out in the primary care
setting or did not analyse the data by ITT. Data from
individuals with certain diseases (eg, cardiovascular
disease or diabetes) and speciﬁc sectors of the popula-
tion (eg, pregnant women) were included if the study
had been carried out in the primary care setting.
Information sources
Searches were conducted in three databases, MEDLINE
(via PubMed), Web of Science and SCOPUS, and sup-
plemented with a manual search of the archives of three
key journals: Addiction, Tobacco Control, and Nicotine and
Tobacco Research. In addition, the periodic alerts from
Smoking and Tobacco Abstracts and News (STAN
Bulletin)28 were searched, followed by a reverse search
based on references cited in the key articles recovered
using the initial search strategy. The search period
extended from the inception of the database or journal
through the end of February 2014. The entire search
process was supported by bibliographic specialists of the
School of Medicine, Universitat Autònoma de
Barcelona.
Search
The search strategy combined a controlled vocabulary
and free-text terms; the full strategy used for MEDLINE
(via PubMed) is described in online supplementary
annex 1.
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Study selection and data collection process
All references identiﬁed in the different databases were
imported into Reference Manager (V.12), and duplicate
bibliographic records were eliminated.
Ten reviewers participated in the selection process.
Each article identiﬁed was randomly assigned to two
reviewers, who independently reviewed the title and
abstract to identify articles meeting the inclusion criteria
for full-text review. Each reviewer received the basic cit-
ation data, the abstract and an Excel database containing
the ﬁelds to be considered (study population, primary
care setting, type of intervention and results obtained).
Any disputed selections were resolved by a third reviewer.
Two different reviewers evaluated the full text of the
selected articles to conﬁrm their eligibility according to
the inclusion criteria. In case of any disagreement, a
third reviewer made the ﬁnal decision. An ad hoc form
was designed to extract data from the full text of the
selected articles.
Risk of bias in studies
To assess the methodological quality of the selected
studies, the SIGN (Scottish Intercollegiate Guidelines
Network) checklist for RCTs was used, along with a
version of the SIGN guidelines adapted for non-
randomised studies (see online supplementary annex
2). The quality review included 10 general items and
overall evaluation item that classiﬁed each study as high
quality, acceptable or low quality. A study was considered
high quality if it met the majority of the criteria, showed
little or no risk of bias, and the results seemed unlikely
to change due to additional research. Quality was con-
sidered acceptable if most criteria were met but there
were some ﬂaws and an associated risk of bias, and
further study could change the reported conclusions.
Studies that failed to meet the majority of the criteria,
had major ﬂaws, and whose conclusions were likely to
change in light of further studies were considered low
quality and excluded from analysis.
Synthesis of results
The present review is narrative because of the great het-
erogeneity of the studies included. Differences in the
age of participants, populations studied, diversity in sta-
tistics and outcome measures made unfeasible to report
a global effect size. Moreover, the type and duration of
the interventions and follow-up varied widely among the
studies, and consequently a formal meta-analysis to
combine study results was not possible. The results of
the selected studies were summarised in tables that show
the years of the study, the population, type of study, type
of intervention, major results, author conclusions and
methodological quality of the study.
RESULTS
Study selection
A total of 1651 records were collected, of which 504
(30.5%) were identiﬁed as duplicates. Once the
independent paired review of the 1147 records was com-
pleted, 1026 (89.5%) were excluded from further ana-
lysis. Of the 121 publications selected, 4 were rejected
after a second paired review of the corresponding
abstract. Full-text review was completed for 117 (96.7%)
articles. After paired review, 10 publications (9 studies)
were ﬁnally included in the present narrative review.
The reasons for discarding articles at the ﬁrst and
second levels of paired review are shown in ﬁgure 1.
Study characteristics
The primary characteristics of the nine studies included
in the present review, as well as the major results and
conclusions are detailed in table 1 (panels A and B).
Eight studies are RCTs and one is a non-RCT.29 Two
publications refer to different aspects of the same
RCT.30 31 Inclusion periods ranged from the mid-1990s
to the ﬁrst decade of the 21st century. Five of the studies
were carried out in the Spanish population and the
remainder in the German population,32 the USA,33
China34 and Holland.35 Of the nine studies included,
eight were carried out in the general population and
one in patients with chronic obstructive pulmonary
disease.34 The number of smokers participating ranged
from 89 in Spain36 to 3562 in China.34 The selected
studies included a total of 10 204 participants and the
follow-up varied from 6 to 48 months. Some studies
included smokers of any quantity of cigarettes, while
Twardella and Brenner included only those who smoked
more than 10 cigarettes daily and Daughton et al33
required 20 cigarettes daily for inclusion. Six studies had
a control group receiving usual care, and all nine com-
pared at least two groups. The measurement of exhaled
carbon monoxide (CO) was the main biochemical
means of conﬁrming abstinence; only two studies35 mea-
sured cotinine, in urine and saliva, respectively.
In some trials, the intervention occurred with smokers
at the preparation phase,29 34 35 37 which generally, but
not always, increased the number who quit smoking and
decreased the number who abandoned. The trial by
Cabezas et al30 and Puente et al31 included smokers at all
stages of the change process. In the study by Torrecilla
et al,38 despite focusing on a population at all stages of
change, patients in the preparation phase were accepted
as referrals from other practices.
Risk of bias within studies
All of the studies obtained an ‘acceptable’ quality score
(table 2). The major quality problems were the lack of
blind interventions and the heterogeneity of losses to
follow-up, ranging from 1.2% to 76%; in fact, three of
the studies30 31 35 37 reported more than 40% loss to
follow-up and a lack of blinding in the interventions.
All of the studies applied ITT analysis (loses to
follow-up were considered as smokers). All of the
selected studies, as expected because it was a criterion
for inclusion, conﬁrmed tobacco abstinence by some
biochemical test.
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Table 1 Major characteristics of the articles included in the review of complex interventions to promote smoking cessation
Panel A
Reference (year
of publication)
Type of
study
Study population
(inclusion criteria, study location)
Key elements of
intervention Type of intervention
Daughton et al
(1998)33
RCT 369 smokers of 20 or more cigarettes/day,
aged 19–65 years recruited in Nebraska
(USA). Period NS
Presential visits
Professional
training
Medication
Control group: two primary care visits devoted to smoking cessation
and 10 weeks of wearing a placebo patch
Intervention group: two primary care visits devoted to smoking
cessation and 10 weeks of wearing a nicotine patch
Set a D-day. Contacted participants for follow-up visits at 3, 6 and
12 months after D-day (4 visits). Training was provided, although the
authors do not indicate its duration. Intervention model not described
Grandes et al
(2000)29
Non-RCT 1768 smokers in the preparation phase of
change; primary care patients in the Basque
Country (Spain) in 1995–1996
Presential visits
Telephone calls
Medication
Control group: usual care
Intervention group: intervention based on clinical practice
recommendations and based on identifying smokers, advise them
about smoking cessation, help them through motivational interview to
stop smoking, encourage the use of NRT to stop smoking and
schedule follow-up visits
Training (20 h) provided for all participants. Intervention group
participates in 3 office visits. The time the doctor spends on each
visit was measured in a sample of 50 visits: 23 s were spent
identifying the smoker; 3 min, 28 s on counselling, motivating and
offering a treatment plan. Patients who declared a desire to quit
smoking followed a treatment plan monitored by the doctor during 3
in-person appointments and 2 telephone calls, and received a
stop-smoking guide. A D-day was established
Torrecilla et al
(2001)38
RCT 304 smokers older than 18 years recruited in
Salamanca (Spain) in 1997
Presential visits
Written support
materials
Medication
Patients with low nicotine dependence were randomised to two types
of intervention (doctor’s counselling alone or within a ‘minimal
intervention’, conducted systematically). Patients with moderate-high
nicotine dependence received minimal intervention and NRT
(nicotine patch). Systematic minimal intervention (systematic
antismoking counselling at any opportunity during the office visit,
provision of written support materials that follow SEPAR
recommendations, psychological support and scheduled follow-up
visits to monitor the patient’s process of breaking the habit. In the
minimal intervention group, follow-up visits were scheduled at
15 days and 1, 2, 3, 6 and 12 months (6 visits). Transtheoretical
model of change was used. D-day was set. A third group within the
MI group served as a control group
Twardella and
Brenner (2007)32
Clustered
RCT
577 smokers aged 36–75 years in Germany
in 2002–2003
Presential visits
Professional
training
Financial
remuneration
Medication
Control group: usual care
Intervention group 1 (training+incentive, TI): 2 h of training for
doctors on promoting smoking cessation (counselling,
transtheoretical model of change, medications) and financial
remuneration of the doctor for every patient who remains a
non-smoker at 12-month follow-up
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Table 1 Continued
Panel A
Reference (year
of publication)
Type of
study
Study population
(inclusion criteria, study location)
Key elements of
intervention Type of intervention
Intervention group 2 (training+medication, TM): 2 h of training for
doctors on promoting smoking cessation (counselling,
transtheoretical model of change, medications) and free medications
(nicotine and/or bupropion) for their patients who want to quit.
Intervention group 3: This group received TI+TM
TI and TM group doctors received a free 2 h group training session,
using a transtheoretical model of change. Groups of doctors were
randomised to 3 study arms. No information about length of
intervention or number of visits. No indication of D-day
Secades-Villa et al
(2009)36
RCT 89 smokers aged 19–65 years in Asturias
(Spain). Period NS
Presential visits
Telephone calls
Written support
materials
Brief counselling: in about a 7 min session, the doctor provides brief
counselling, informing about the negative effects of tobacco and the
advantages of smoking cessation. The following recommendations
are made: set a D-day, reduce cigarette consumption by one-third
the week before D-day, carry out activities different from smoking a
cigarette (physical exercise, handicrafts, etc). Hand out a brochure
on the ‘6 reasons and 6 steps to stop smoking’
Self-help manual with telephone follow-up: carried out by the doctor
and two primary care nurses. The intervention began with brief
counselling (same as above) and distribution of 25-page
multicomponent self-help manual covering the phases of preparation,
cessation and maintenance (included the essential motivation
messages, emphasising the advantages of smoking cessation, a
weekly reduction in the number of cigarettes smoked, controlling the
symptoms of withdrawal, identifying risk situations and preparing for
D-day). Four follow-up telephone calls were made, in weeks 1, 4, 8
and 12. In each call, the smoker verified his or her cessation status,
whether he or she was practising the manual’s recommendations,
and was offered brief counselling
Intensive behavioural therapy: carried out by a clinical psychologist
and based on the 5-week Becoña smoking cessation programme of
a 20 min session each week. The programme includes information
about the effects of tobacco, a contract in which the patient makes a
commitment to stop smoking and to attend the weekly sessions,
self-reporting and graphic representation of the cigarettes smoked,
gradual reduction in the number of cigarettes smoked, social support
for smoking abstinence, controlling the symptoms of withdrawal,
biochemical feedback on cigarettes smoked (measurement of
exhaled CO) and strategies to avoid relapse
Ramos et al
(2010)37
RCT Professional
training
Control group: MI. Health professionals received basic preparation
and training
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Table 1 Continued
Panel A
Reference (year
of publication)
Type of
study
Study population
(inclusion criteria, study location)
Key elements of
intervention Type of intervention
287 smokers older than 18 years with the
intention to quit smoking, in Mallorca (Spain)
in 2005–2006
Presential visits
Group
interventions
Medication
Intervention group I: III. Health professionals received prior training.
Individual intervention consisted of 6 standardised weekly visits. The
protocol recommended that the first visit last 20 min and the
remainder 10 min, although more time was actually spent
Intervention group II: IGI. Health professionals received prior training.
The IGI consisted of 6 standardised weekly visits lasting 60 min
each, although in practice more time was spent
After the intervention, visits were scheduled after 1, 2, 3, 6, 9 and
12 months. The Prochaska model was used. NRT and bupropion
were used at the doctor’s discretion. A D-day was set
Cabezas et al
(2011)30
Puente et al
(2011)31
Clustered
RCT
2827 smokers aged 14–85 years, primary
care patients in Spain in 2003–2005
Professional
training
Presential visits
Medication
Control group: usual care
Intervention group: implementation of clinical practice guidelines
recommendations during 6 months, including motivational interviews
with smokers at the precontemplation-contemplation stage of
change, a brief intervention with smokers in the preparation-action
stage who do not want additional help, intensive intervention with
pharmacological support for smokers in the preparation-action stage
who want help, and reinforcement of the intervention with patients in
the maintenance stage. The Prochaska model was used. A D-day
was set. Medications were used at the doctor’s discretion. A
motivational intervention was used, and 6 office visits (intensive
intervention). A 20 h training activity was provided before the trial
Lou et al (2013)34 Clustered
RCT
3562 smokers with COPD in 14 primary
care centres in the rural city of Xuzhou,
China in 2008
Presential visit
Written materials
All participants had an appointment with their doctor and the care
team in the healthcare centre. Those who want to stop smoking
receive a brochure indicating the toxic components in cigarettes,
diseases related to smoking, benefits of smoking cessation, ways to
stop smoking.
Control group: usual care
Intervention group: behavioural intervention and motivational
interview
Two-year intervention. No pharmacological treatment provided during
the study
Smit et al (2013)35 RCT 414 smokers older than 18 years in the
Netherlands, motivated to stop smoking
within 6 months and with internet access in
2009–2010
Presential visits
Feedback letters
Telephone calls
Intervention group 1 (multiple tailoring): after setting a D-day to stop
smoking, participants received 4 feedback letters: at the starting
point, 2 days after D-day, after 6 weeks, and after 6 months. This
feedback was personalised according to the characteristics of the
participant. The feedback letters were 4–5 pages long and included
7 components: (1) introduction to the intention to stop smoking, (2)
feedback related to the patient’s attitude, (3) feedback related to the
social influences surrounding tobacco, (4) feedback about how to
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Table 1 Continued
Panel A
Reference (year
of publication)
Type of
study
Study population
(inclusion criteria, study location)
Key elements of
intervention Type of intervention
handle situations that made him or her want to smoke, (5) feedback
about actions that patients want to take to stop smoking, (6)
feedback on how to handle situations where not smoking is difficult
and (7) closing. Participants had access to the letters after they had
completed an online questionnaire. It was also possible to send
additional feedback letters by email
Intervention group 2 (multiple tailoring+counselling group): after
receiving the first personalised letter, participants were prompted to
schedule a visit with the nurse within the following 6–8 weeks for a
personalised counselling session with a set protocol (instead of a
third personalised letter). After 6 months, the nurse telephoned the
patients to gather information about how they were progressing with
smoking abstinence
Control group: usual care and recommendations
Panel B
Reference (year
of publication) Smoking abstinence Main results Author conclusions
Quality of
the study*
Daughton et al
(1998)33
3, 6 and 12 months after D-day;
confirmed by urine cotinine
Compared with placebo control group,
intervention group participants showed
greater abstinence at 3 months (23.4% vs
11.4%; p 0.01) and 6 months (18.5% vs
10.3%; p 0.05). Abstinence at 1 year was
14.7% in the intervention group and 8.7% in
the control group (p=0.07)
Use of the nicotine patch together with a
brief intervention in primary care increased
smoking cessation at 6 months. The duration
of counselling, age of the patient, and the
level of nicotine dependency may be
important factors related to successful
tobacco abstinence using nicotine patches
for treatment
Acceptable
Grandes et al
(2000)29
6 and 12 months; confirmed by exhaled
CO
The programme results were 5 percentage
points higher in sustained abstinence at
1 year, with 7.1%
Programmes that combine counselling on
how to stop smoking with the offer of
support, follow-up, and the prescription of
nicotine patches to those smokers who want
to stop smoking are feasible and effective in
daily clinical practice
Acceptable
Torrecilla et al
(2001)38
Continuous abstinence at 6 and
12 months; confirmed by exhaled CO
Point prevalence abstinence achieved at
1 year after the MI was 39% (29.4–49.3%)
and continuous abstinence was 30.9%
(29.4–49.3%) compared with 11% (5.6–
18.8%) point prevalence abstinence in the
counselling-only group (p<0.0001). In the
NRT group, point prevalence abstinence was
Primary care is an ideal framework for
antismoking interventions, using any of the
established types of intervention: medical
counselling only, systematic MI or
specialised drug treatments using NRT;
therefore, these types of intervention should
Acceptable
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Table 1 Continued
Panel B
Reference (year
of publication) Smoking abstinence Main results Author conclusions
Quality of
the study*
35.3% (24.1–47.8%) and continuous
abstinence was 30.8%
form part of routine daily activities in the
primary care practice
Twardella and
Brenner (2007)32
Continuous abstinence at 12 months Smoking abstinence at 12 months was 3% in
the control group, 3% in the intervention with
an economic incentive for doctors, 12%
when smokers were provided medications
free of charge and 15% when both
interventions were combined. The
intervention with free medication had an OR
to stop smoking was 4.77 (95% CI 2.03 to
11.22)
Providing medications free of charge, along
with short courses or specific training for
healthcare professionals who care for those
patients could lead to success in smoking
cessation
Acceptable
Secades-Villa
et al (2009)36
12 months; confirmed by exhaled CO At 12-month follow-up, intensive behavioural
therapy (42.8% abstinence) was more
effective than a self-help programme (27.5%)
and the latter was superior to counselling
(12.9%). This pattern was also observed in
continuous abstinence. Treatment adherence
was higher in the intensive behavioural
therapy group (82.8% of all participants
attended all therapy sessions) than in the
self-help group (61.8% completed the full
programme)
Results confirm a dose–response effect in
the treatment of smokers and indicate high
acceptability of intensive behavioural
programmes in primary care
Acceptable
Ramos et al
(2010)37
Continuous abstinence at 12 months;
confirmed by exhaled CO
Continuous abstinence at 12 months was 1%
in the control group, 7.4% in the III and 5.4%
in the IGI. No statistical differences between
individual and group interventions were
observed. No differences were found
between the intensive interventions and
control group
Intensive interventions were less effective
than expected
Acceptable
Cabezas et al
(2011)30
Puente et al
(2011)31
12 and 24 months; confirmed by exhaled
CO
Continuous abstinence was 8.1% in the
intervention group and 5.8% in the control
group at 1 year (p=0.014). The odds of
smoking cessation in the intervention group
compared with controls were 1.50 (95% CI
1.05 to 2.14)
An intervention based on the transtheoretical
model of change significantly increased
abstinence at 2-year follow-up
Acceptable
Lou et al
(2013)34
24, 30 and 48 months postintervention;
confirmed by exhaled CO
Continuous abstinence was greater in
members of the intervention group than
control group between months 24 and 30
Behavioural intervention doubled the
smoking cessation results in patients with
COPD
Acceptable
Continued
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Components of the interventions
The studies based the multicomponent interventions for
smoking cessation on the following components: raising
awareness of the problem, education, motivation, behav-
ioural change and medications. The methodologies
used in the interventions were mainly individual or
group sessions, telephone conversations, brochures or
quit-smoking kits, and medications. Other approaches
included economic incentives for doctors and no-cost
medications for smokers,32 ‘homework’ assignments,
and multifactor, community-based care.
In most studies, the control groups received usual
primary care attention, including brief advice to stop
smoking or an informational brochure about the
harmful effects of tobacco on health. Only Daughton
et al33 provided a placebo patch, worn for 10 weeks, and
two primary care visits dealing with smoking cessation:
their objective was to assess the effectiveness of the nico-
tine patch and they sought to ensure that the control
group had the same characteristics. The study by
Secades-Villa et al36 took a different approach, delivering
some type of intervention in all three study arms.
Behavioural interventions were mainly mixed models
based on clinical practice guidelines: behavioural
therapy, the motivational interview proposed by Miller
and Rollnich,39 and the transtheoretical model of
change.40 Most of the Spanish trials reviewed30 31 37 38
stand out for the following common characteristics: use
of the model developed by Prochaska and Diclemente,
advance training for participating health professionals,
selection of a D-day to stop smoking and the use of
medication at the discretion of the prescribing phys-
ician. In the study by Cabezas et al and Puente et al, a
patient recruitment model adjusted to ‘real-life’ condi-
tions and usual clinical practice was used, attracting
patients from the general population who visited their
health professionals spontaneously.
As can be seen in table 1 (speciﬁcally panel B) the
majority of the included studies (seven out of nine) set a
D-day for the patients to stop smoking.
Effectiveness of multicomponent interventions
Behavioural interventions
Scaled interventions based on the transtheoretical
model of change that included a motivational interview
with smokers who visited a family doctor or nurse were
associated with increased continuous tobacco abstinence
at 138 and 2 years of follow-up;30 31 gender was not a pre-
dictor of successful cessation. For instance, three studies
using intensive interventions reported signiﬁcant posi-
tive effects at 1 year: six visits with a healthcare profes-
sional achieved 8.1% continuous abstinence, compared
with 5.8% in a control group;30 a comparison of an indi-
vidual intervention, group intervention and control
group observed abstinence rates of 7.4%, 5.4% and 1%,
respectively;37 and a complex intervention achieved
30.8% continuous abstinence compared with 11% in the
control group.38 Twardella and Brenner did not obtainT
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better cessation rates than controls (3%) when doctors
provided an intervention based on counselling and the
transtheoretical model of change, but did see improve-
ment (12%) when free prescription medications were
provided for patients.32 The intervention proposed by
Smit et al35 combined two methodologies: Internet feed-
back messages and meetings with nurses based on the
I-Change Model (ICM) supported by Prochaska’s theor-
ies did not produce signiﬁcant results.
The 2-year behavioural intervention proposed by Lou
et al in patients with chronic obstructive pulmonary disease
who smoke is based on a motivational interview. Their
study obtained an abstinence rate of 46.4% (control
group: 3.4%) at 24 and 30 months postintervention.34
Intensive behavioural therapy based on a 5-week
smoking cessation programme consisting of 20 min
weekly sessions obtained continuous abstinence of
42.8% at 12 months, compared with 12.9% for brief
counselling.41 This programme included information
about the effects of smoking, a contract in which the
patient makes a commitment to stop smoking and
attend the weekly sessions, self-recording and graphic
representation of cigarettes smoked, gradual reduction
in the number of cigarettes smoked, social support for
abstinence, controlling the symptoms of tobacco with-
drawal, biochemical feedback on cigarettes smoked
(measurement of exhaled CO) and strategies to prevent
relapse.36
In the studies that analysed treatment efﬁcacy based
on intensity or complexity, the observation was that the
more components the intervention had, the more
follow-ups the professional provided, and the more indi-
vidualised these were, the better were the results in
terms of continuous abstinence from smoking. In the
study by Secades-Villa et al,36 the least intensive interven-
tion, a self-help manual with a follow-up telephone call,
obtained lower rates of continuous abstinence at
12 months than the most intensive intervention arm, but
more than twice the rates achieved by patients who
received only brief counselling (27.5%, 42.8% and
12.9%, respectively). Although lower than expected,
Ramos et al observed non-signiﬁcantly higher rates of
continuous abstinence at 12 months from intensive
interventions (7.4% in the individual and 5.4% in the
group sessions), compared with the control group (1%).
The authors point out that this effect could be
explained by the initial participant characteristics: they
more strictly selected smokers for the intensive interven-
tions in primary care, and the health professionals pro-
vided few prescriptions for drug therapies.37
The study by Twardella and Brenner32 demonstrated
greater effectiveness in smoking cessation in the
Figure 1 Flow chart of article selection for the study.
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Table 2 Quality of the randomised clinical trials included in the review, based on SIGN guidelines (continued on following page)
Ítem Daughton et al (1998)
Grandes et al
(2000)
Torrecilla
et al (2001)
Twardella et al
(2007)
Secades-Villa
et al (2009)
1. The study addresses an appropriate and clearly focused
question?
Yes Yes Yes Yes Yes
2. The assignment of participants to treatment groups is
randomised?
Yes No Yes Yes Yes
3. An adequate concealment method is used Yes Yes Can’t say Can’t say Can’t say
4. Participants and investigators are kept ‘blind’ about treatment
allocation
Yes No Can’t say No Can’t say
5. The treatment and control groups are similar at the start of the
trial
Yes Yes Yes Yes No
6. The only difference between groups is the treatment under
investigation
Yes Yes Yes Yes Yes
7. All relevant outcomes are measured in a standard, valid and
reliable way
Yes Yes Yes Yes Yes
8. What percentage of the individuals or clusters recruited into
each treatment arm of the study dropped out before the study
was completed?
1.1% at 3 months, 1.6 at
6 months and 2.2% at
1 year
Control group:
1.8%
Intervention
group: 4.6%
CG: 6%
Isolated
advice :3%
NRT: 7.7%
CG:19%
The interventions
14–17%
1.2%
9. All the participants are analysed in the groups to which they
were randomly allocated (often referred to as intention-to-treat
analysis)
Yes Yes Yes Yes Yes
10. Where the study is carried out at more than one site, results
are comparable for all sites
Yes Yes Does not
apply
Yes Does not apply
11. How well was the study done to minimise bias? Acceptable Acceptable Acceptable Acceptable Acceptable
12. Taking into account clinical considerations, your evaluation of
the methodology used, and the statistical power of the study,
are you certain that the overall effect is due to the study
intervention?
Yes Yes Yes Yes Yes
Ítem
Ramos et al
(2010)
Cabezas et al and
Puente et al (2011) Lou et al (2013) Smit et al (2013)
1. The study addresses an appropriate and clearly focused question? Yes Yes Yes Yes
2. The assignment of participants to treatment groups is randomised? Yes Yes Yes Not clear
3. An adequate concealment method is used Yes Yes No Yes
4. Participants and investigators are kept ‘blind’ about treatment
allocation
Yes No No No
5. The treatment and control groups are similar at the start of the trial Yes Yes Yes Yes
6. The only difference between groups is the treatment under
investigation
Yes Yes Yes Can’t say
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presence of symptomatology or previous diseases related
to smoking and older age, but an economic incentive
for health professionals was not effective. On the other
hand, Lou et al34 found a relationship between effective-
ness and a non-smoking family environment and a
family doctor and nurse who were not smokers.
According to some studies, speciﬁc training for health-
care professionals who care for smokers who want to
stop smoking may increase their probability of
success.29 32 Twardella and Brenner32 point out that
other studies had previously shown training programmes
to have beneﬁcial effects on the number of smokers
identiﬁed and offered advice and support for quitting.
However, the effect of the increased efforts on smoking
cessation could not be proved.
Finally, in primary care—as has occurred in other set-
tings—a dose–response effect has been observed in the
interventions, with greater abstinence as more interven-
tions are provided. In addition, intensive interventions
typically have high rates of acceptance in the primary
care setting.36
Pharmacological interventions
The pharmacological interventions identiﬁed include two
classes of drugs that are effective in smoking cessation:
nicotine replacement therapy (NRT) and bupropion. This
review did not include any studies of complex interven-
tions that included varenicline use in primary care.
The use of nicotine patches along with a brief inter-
vention, compared with a group that received placebo
patches, increased continuous tobacco abstinence at
6 months (18.5% vs 10.3%) and 12 months (14.7% vs
8.7%).33 In another study, continuous abstinence in
patients with moderate-high nicotine dependence who
used NRT was 30.8% at 1 year, compared with 11% in
the group that received only the doctor’s advice.38
Although we excluded some studies from the review
for their lack of biochemical conﬁrmation,42–44 they
offer several contributions to this discussion: One study
showed that the length of the counselling,44 in addition
to the age of the patient and nicotine dependency,33 are
important factors related to the success of smoking
abstinence, and providing treatment to break the
smoking habit free of charge can increase the probabil-
ity of success.32 Therefore, programmes delivered in
routine daily practice in the primary care setting that
combine counselling, offers of assistance, follow-up and
prescriptions for treatments that speciﬁcally help to
break the smoking habit are feasible, effective29 and
safe43; furthermore, these complex interventions are
more effective than minimal counselling.42 43 The com-
bined use in primary care of bupropion, NRT, cognitive
behavioural therapy and minimal intervention is feas-
ible, safe and achieves results ranging from 20% to
29.6% of continuous abstinence at 12 months, with no
differences between them but an advantage over coun-
selling alone; the only obstacle is adherence to
treatment.43T
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In the absence of a standard drug therapy in all studies
and of any comparison of different medications and
doses, it was impossible to analyse a speciﬁc effect for
each drug prescribed at the discretion of the attending
physician as a complement to some of the interventions
reviewed. We assumed that medications were prescribed
in accordance with current guidelines but were unable to
analyse their effects on patient outcomes.
Follow-up
One of the main inclusion criteria for publications to be
reviewed was at least 6 months of postintervention
follow-up. This was because shorter time intervals carry a
very high probability of relapse and abstinence is not
considered deﬁnitive until at least 6 months have passed
without smoking. Therefore, the included interventions
had a follow-up of 6 months or more. Most of the publi-
cations reported follow-up of 6 or 12 months. Cabezas
et al30 and Puente et al31 also conducted a 2-year
follow-up, and Lou et al34 reported on the longest
follow-up, reaching a maximum of 5 years.
DISCUSSION
The objective of the present review was to summarise on
the effectiveness of multicomponent interventions with
respect to continuous abstinence from tobacco. We
included both randomised and non-randomised clinical
trials involving smokers older than 18 years and attended
in the primary care setting that assess continuous abstin-
ence (at least 6 months) and include biochemical con-
ﬁrmation. Nine studies, eight RCTs and one non-RCT
with these characteristics were identiﬁed.
In the present review, we found that the multicompo-
nent interventions included increased abstinence in the
long term, achieving continuous abstinence after 1 year
from about 7% to just over 40% in comparison with
control groups (usual care). This wide range of percen-
tages can be attributed to differences in patient selection
criteria. Owing to the heterogeneity and differences in
intensity of the interventions included, it can be compli-
cated to determine the duration and type of interven-
tion that is most effective in achieving better rates of
continued abstinences. In general, we observed that with
more components, more follow-ups by the health profes-
sional and more intense interventions, better smoking
abstinence results were achieved. In addition, multicom-
ponent strategies were more effective when medications
were used and a ‘D-day’ was set.
Biochemical conﬁrmation, measuring either exhaled
CO or cotinine in urine or saliva, provides researchers
with a far more rigorous assessment than a patient’s self-
report of continuous smoking cessation, as does long-
term follow-up. Unfortunately, four studies reported
more than 20% loss to follow-up.30 31 34 35 37
The published literature has observed that brief coun-
selling in the healthcare setting increases the frequency
of efforts to stop smoking. The systematic review by
Aveyard et al45 found a risk ratio (RR) of 1.24 (95% CI
1.16 to 1.33) for brief counselling, less than that of
behavioural support (RR=2.17; 95% CI 1.52 to 3.11) or
NRT (RR=1.68; 95% CI 1.48 to 1.89). The effect of brief
counselling on the rates of smoking cessation seems to
be small; in a 2008 systematic review, Stead and collea-
gues found that brief counselling increased these rates
only 1–3% compared with attempts made without
medical assistance. More intensive interventions also
contributed a beneﬁt, although scant. A doctor’s advice
helps smokers to stop smoking, even if it is brief counsel-
ling. It appears that the intensity and follow-up can
achieve higher rates of cessation.13 Individual counsel-
ling is frequently used to help patients stop smoking,
but there is insufﬁcient evidence to establish whether
higher intensity counselling is more effective.46 The
effectiveness of drug therapies is more clear: a review by
Wu et al47 found that NRT, bupropion and varenicline
are effective complementary methods of smoking
cessation.
Our data concur in large part with an earlier review,14
which reported that the effectiveness of multiple/
complex interventions in achieving sustained smoking
cessation in adult primary care patients had an OR of
2.2 (95% CI 1.7 to 2.8), compared with a control group.
The same authors found differences between the effect
of brief counselling and intensive counselling with a
multicomponent intervention (OR 1.37, 95% CI 1.20 to
1.56) and also when medications were used to help the
smoker (OR 3.45, 95% CI 2.8 to 4.2).
With respect to intervention models, various trials ana-
lysed for this review used the transtheoretical model of
change with positive results; however, reviews of litera-
ture have not arrived at a clear conclusion about the
effectiveness of this model.48–50 Although the objective
of the present review was not to speciﬁcally evaluate this
model, the clinical trials indicate that it is well accepted
by health professionals and the study populations.
On the other hand, the Cochrane review by Stead and
Lancaster15 points out that, without any doubt, the com-
bination of behavioural strategies with drug therapies
has been shown to be clearly useful, which is in accord-
ance with the data reported in this review.
Therefore, usual clinical practice should include inter-
ventions with more than one component, adapting the
characteristics of the intervention to the type of service
offered, and time and training of healthcare personnel
is necessary to achieve a useful strategy. With respect to
the research, more studies must be designed to clarify
the combination of behavioural strategies and use of
medications that is most effective in usual practice in
speciﬁc population groups, and the cost-effectiveness of
those combinations.
Limitations
One of the major limitations of the present review, and
of all reviews in general, is the publication bias that in
this case we attempted to control by searching for data
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in the STAN Bulletin, which publishes all types of news
items and other information. Furthermore, it was not
possible to include references from presentations at con-
ferences and meetings, although we believe that the
work with the greatest potential importance has been
published in journals with an impact factor. We have
only included those studies published in English or
Spanish. Another limitation of this study, despite the
rather strict inclusion criteria, is that the age of the parti-
cipants, the populations studied, and the type and dur-
ation of the interventions and follow-up contributed to
the heterogeneity of the results. In clinical trials, the
most frequently recommended measurement of continu-
ous smoking cessation is ‘continuous abstinence’,
deﬁned as no use of any amount of tobacco from the
day the individual stops smoking until the day data are
analysed. This deﬁnition has also been called ‘sustained
abstinence’ and ‘prolonged abstinence’.27 The
Cochrane Tobacco Addiction Group also references
other types of abstinence: ‘point prevalence abstinence’
for short periods without smoking and ‘prolonged
abstinence’, which is similar to ‘continuous abstinence’
and analyses abstinence after a grace period of about
2 weeks.51 In order to strengthen the reliability of the
results, we decided to follow the recommendations by
West et al52 and of the Society for Research on Nicotine
and Tobacco Europe53 where they propose to undertake
a biochemical veriﬁcation to conﬁrm smoking cessation.
However, we may have incurred into some selection bias
due to the fact that we have only included studies with
biochemical veriﬁcation of smoking cessation.
Another possible bias in this review is the loss to
follow-up; three of the studies reported more than 40%
loss to follow-up (one of them reported a 76% loss). In
order to limit this bias and to ensure a certain level of
quality, we included only trials that used an ITT
approach. In addition, we must take into account the
increased motivation to stop smoking that is normally
present in smokers who agree to participate in clinical
trials. This review likely underestimated the effectiveness
of some of the multicomponent interventions: In many
RCTs, the control group is offered brief counselling by
healthcare professionals, which in and of itself increases
smoking cessation. Another limitation of the included
studies is the lack of blinded interventions, but it is
important to remember that the very nature of the
behavioural interventions in many cases impede efforts
to achieve a blind intervention.
The search ended in February 2014 and it might be
quite old, the analysis and subsequent steps took us
longer than expected. However, we believe that the
number of publications will have not changed and
results will have not changed signiﬁcantly.
Our search strategy included the term ‘complex inter-
vention’; consequently, we reviewed those articles that
mentioned the terms ‘complex’ or ‘multiple’ in their
title or abstract. This search strategy brought us to select
nine trials, mainly conducted in Spain and in somewhat
low impact factor journals. Maybe the research question
is a topic of concern in the Spanish primary care com-
munity. Besides, there is not a clear consensus on what it
is a ‘complex intervention’. Consequently, we may have
omitted the analysis of some of the components that
deﬁne an intervention as a complex one, such as the
participation of some disciplines, changes in the envir-
onment or the effect of different professionals. All these
aspects could be clariﬁed in future reviews, but most
studies do not offer this information on their
publications.
Study implications
Future studies of complex interventions to achieve
smoking cessation should use standardised methods to
evaluate outcomes, as proposed by Hughes et al.27 On
the other hand, as complex interventions are involved,
interventions based on clinical practice guidelines must
be standardised to incorporate the key elements of those
guidelines, basically focused on behavioural and
pharmacological elements. We therefore, believe that
clinical practice guideline should recommend interven-
tions with two or more components. Another recom-
mendation is that the studies should analyse
cost-effectiveness.
On the other hand, the majority of the interventions
were carried out in European populations (mostly in
Spain), two studies in the USA population33 and one in
China.34 Consequently, it is not clear whether the ﬁnd-
ings are applicable to other populations, and we believe
it is necessary to develop this type of interventions and
evaluate their effectiveness in other populations.
CONCLUSIONS
Very few studies have evaluated complex/multicompo-
nent interventions in the primary care setting that are
designed to promote smoking cessation, even though
this approach is useful, effective, safe, and achieves
greater long-term continuous cessation (between 7%
and 40%) than usual care and counselling alone (which
also is effective). Behavioural interventions are effective
and have a dose–response effect. In fact, the more
support the smoker receives—more components, more
follow-up by the health professional, longer duration—
and the more personalised is the intervention, the
greater the continuous smoking cessation achieved.
Nonetheless, no differences were observed between the
different types of intervention. The multicomponent
strategies are more effective when the smoker sets a
‘D-day’ and medications are prescribed. The drugs used
in the studies analysed (NRT and bupropion) are useful,
safe and effective, with no differences observed between
them. The use of other strategies such as providing
patients with free medication can increase the success of
these treatments. Therefore, a complex intervention to
help smokers quit should include: several monitoring
visits, longer periods to follow-up patients, behavioural
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components and possibility to set a ‘D-day’ and pre-
scribe medication. Despite the evidence that multicom-
ponent interventions are effective, it is not clear which
of the components of the different interventions are key.
Further research is needed to determine which combi-
nations are most efﬁcient.
Author affiliations
1Unitat de Suport a la Recerca Barcelona, Institut Universitari d’Investigació en
Atenció Primària Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain
2Centre d’Atenció Primària (CAP) Passeig de Sant Joan, Institut Català de la
Salut (ICS), Barcelona, Spain
3Department of Medicine, Universitat Autònoma de Barcelona, Barcelona,
Spain
4Centre d’Atenció Primària (CAP) Florida Nord, Institut Català de la Salut
(ICS), Hospitalet de Llobregat, Barcelona, Spain
5Centro de Salud Santo Grial, Huesca, Spain
6Centre d’Atenció Primària (CAP) Sant Antoni, Institut Català de la Salut (ICS),
Barcelona, Spain
7Centre d’Atenció Primària (CAP) La Garriga, Institut Català de la Salut (ICS),
La Garriga, Barcelona, Spain
8Unitat de Suport a la Recerca Metropolitana Nord, Institut Universitari
d’Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Sabadell,
Spain
9Centre d’Atenció Primària (CAP) La Llagosta, Institut Català de la Salut (ICS),
La Llagosta, Spain
10Centre d’Atenció Primària (CAP) la Sagrera, Institut Català de la Salut (ICS),
Barcelona, Spain
11Centre d’Atenció Primària (CAP) Esplugues de Llobregat, Institut Català de
la Salut (ICS), Esplugues de Llobregat, Spain
Acknowledgements The authors thank Marta Jordan, Medicine Library,
Universitat Autònoma de Barcelona, for her assistance with the search
strategy; Enriqueta Pujol Ribera, researcher of the Institut Universitari
d’Investigació en Atenció Primària (IDIAP) Jordi Gol, for her comments on the
manuscript and in the process of selecting articles during the revision; and
Edurne Zabaleta, IDIAP Jordi Gol researcher, for her comments and her
assistance with manuscript preparation and submission, supported by Elaine
Lilly (Writer’s First Aid). They also thank IDIAP Jordi Gol for the institute’s
support for the study.
Contributors CMC planned the study. CMC and EP performed the searches,
screened articles in duplicate, abstracted the data and drafted the manuscript.
All authors performed critical analysis of abstracts and main text and assisted
with any unresolved disagreements. All authors were involved in developing
the study. All authors read and approved the final manuscript.
Funding The project has received funding from a Network for Prevention and
Health Promotion in Primary Care (redIAPP, RD12/0005) grant and a research
project grant (PI12/01914) from the Instituto de Salud Carlos III (Institute of
Health Carlos III) of the Ministry of Economy and Competitiveness (Spain),
co-financed with European Union ERDF funds.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement No additional data are available.
Open Access This is an Open Access article distributed in accordance with
the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license,
which permits others to distribute, remix, adapt, build upon this work non-
commercially, and license their derivative works on different terms, provided
the original work is properly cited and the use is non-commercial. See: http://
creativecommons.org/licenses/by-nc/4.0/
REFERENCES
1. World Health Organization. WHO global report on mortality
attributable to tobacco. 2012. http://apps.who.int/iris/bitstream/10665/
44815/1/9789241564434_eng.pdf
2. Gaziano TA, Galea G, Reddy KS. Chronic diseases 2—scaling up
interventions for chronic disease prevention: the evidence. Lancet
2007;370:1939–46.
3. Kahn R, Robertson RM, Smith R, et al. The impact of prevention on
reducing the burden of cardiovascular disease. Circulation
2008;118:576–85.
4. Benowitz NL. Cigarette smoking and cardiovascular disease:
pathophysiology and implications for treatment. Prog Cardiovasc Dis
2003;46:91–111.
5. Fiore MC, Jaen CR, Baker TB, et al. Treating tobacco use and
dependence: 2008 update US Public Health Service Clinical
Practice Guideline executive summary. Respir Care
2008;53:1217–22. http://bphc.hrsa.gov/buckets/treatingtobacco.pdf
(accessed 11 Dec 2014).
6. Tengs TO, Adams ME, Pliskin JS, et al. Five-hundred life-saving
interventions and their cost-effectiveness. Risk Anal
1995;15:369–90.
7. Eckert T, Junker C. Motivation for smoking cessation: what role do
doctors play? Swiss Med Wkly 2001;131:521–6.
8. Kreuter MW, Chheda SG, Bull FC. How does physician advice
influence patient behavior? Evidence for a priming effect. Arch Fam
Med 2000;9:426–33.
9. Ossip-Klein DJ, McIntosh S, Utman C, et al. Smokers ages 50+:
who gets physician advice to quit? Prev Med 2000;31:364–9.
10. Stead LF, Buitrago D, Preciado N, et al. Physician advice for
smoking cessation. Cochrane Database Syst Rev 2013;5:
CD000165.
11. Russell MA, Wilson C, Taylor C, et al. Effect of general practitioners
advice against smoking. BMJ 1979;2:231–5.
12. Lemmens V, Oenema A, Knut IK, et al. Effectiveness of smoking
cessation interventions among adults: a systematic review of
reviews. Eur J Cancer Prev 2008;17:535–44.
13. Stead LF, Bergson G, Lancaster T. Physician advice for smoking
cessation. Cochrane Database Syst Rev 2008;(2):CD000165.
14. Papadakis S, McDonald P, Mullen KA, et al. Strategies to increase
the delivery of smoking cessation treatments in primary care
settings: a systematic review and meta-analysis. Prev Med
2010;51:199–213.
15. Stead LF, Lancaster T. Combined pharmacotherapy and behavioural
interventions for smoking cessation. Cochrane Database Syst Rev
2012;10:CD008286.
16. Craig P, Dieppe P, Macintyre S, et al. Developing and evaluating
complex interventions: the new Medical Research Council guidance.
BMJ 2008;337:a1655.
17. Craig P, Dieppe P, Macintyre S, et al. Developing and evaluating
complex interventions: the new Medical Research Council guidance.
Int J Nurs Stud 2013;50:587–92.
18. Petticrew M, Anderson L, Elder R, et al. Complex interventions and
their implications for systematic reviews: a pragmatic approach.
J Clin Epidemiol 2013;66:1209–14.
19. Dwamena F, Holmes-Rovner M, Gaulden CM, et al. Interventions for
providers to promote a patient-centred approach in clinical
consultations. Cochrane Database Syst Rev 2012;12:CD003267.
20. Grandes G, Sanchez A, Cortada JM, et al. Is integration of healthy
lifestyle promotion into primary care feasible? Discussion and
consensus sessions between clinicians and researchers. BMC
Health Serv Res 2008;8:213.
21. Lau R, Stevenson F, Ong BN, et al. Addressing the evidence to
practice gap for complex interventions in primary care: a systematic
review of reviews protocol. BMJ Open 2014;4:e005548.
22. Wong G, Greenhalgh T, Westhorp G, et al. RAMESES publication
standards: realist syntheses. J Adv Nurs 2013;69:1005–22.
23. Guise JM, Chang C, Viswanathan M, et al. Systematic reviews of
complex multicomponent health care interventions. Research White
Paper. AHRQ Publication No. 14-EHC003-EF. Rockville, MD. Agency
for Research and quality, 2014. http://effectivehealthcare.ahrq.gov/
index.cfm/search-for-guides-reviews-and-reports/?productid=1878
&pageaction=displayproduct. (accessed 11 Dec 2014).
24. Jaakkimainen L, Schultz S, Klein-Geltink J, et al. Ambulatory
physician care for adults. In: Jaakkimainen L, Upshur R,
Klein-Geltink J, Leong A, Maaten S, Schultz S, Wang L, eds.
Primary care in Ontario: ICES Atlas. Toronto: Institute for Clinical
Evaluative Sciences, 2006:53–76.
25. Zwar NA, Richmond RL. Role of the general practitioner in smoking
cessation. Drug Alcohol Rev 2006;25:21–6.
26. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for
systematic reviews and meta-analyses: the PRISMA statement.
Ann Intern Med 2009;151:264–9, W64.
27. Hughes JR, Keely JP, Niaura RS, et al. Measures of abstinence in
clinical trials: issues and recommendations. Nicotine Tob Res
2003;5:13–25.
Martín Cantera C, et al. BMJ Open 2015;5:e008807. doi:10.1136/bmjopen-2015-008807 15
Open Access
group.bmj.com on January 8, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
28. Shatenstein S. Smoking & Tobacco Abstracts & News (STAN
Bulletin). 2014.
29. Grandes G, Cortada JM, Arrazola A. An evidence-based programme
for smoking cessation: effectiveness in routine general practice. Br J
Gen Pract 2000;50:803–7.
30. Cabezas C, Advani M, Puente D, et al. Effectiveness of a stepped
primary care smoking cessation intervention: cluster randomized
clinical trial (ISTAPS study). Addiction 2011;106:1696–706.
31. Puente D, Cabezas C, Rodriguez-Blanco T, et al., ISTAPS study
group investigators. The role of gender in a smoking cessation
intervention: a cluster randomized clinical trial. BMC Public Health
2011;11:369.
32. Twardella D, Brenner H. Effects of practitioner education, practitioner
payment and reimbursement of patients’ drug costs on smoking
cessation in primary care: a cluster randomised trial. Tob Control
2007;16:15–21.
33. Daughton D, Susman J, Sitorius M, et al. Transdermal nicotine
therapy and primary care. Importance of counseling, demographic,
and participant selection factors on 1-year quit rates. The Nebraska
Primary Practice Smoking Cessation Trial Group. Arch Fam Med
1998;7:425–30.
34. Lou PA, Zhu YA, Chen PP, et al. Supporting smoking cessation in
chronic obstructive pulmonary disease with behavioral intervention:
a randomized controlled trial. BMC Fam Pract 2013;14:91.
35. Smit ES, Evers SM, de Vries H, et al. Cost-effectiveness and
cost-utility of internet-based computer tailoring for smoking
cessation. J Med Internet Res 2013;15:e57.
36. Secades-Villa R, Alonso-Perez F, Garcia-Rodriguez O, et al.
Effectiveness of three intensities of smoking cessation treatment in
primary care. Psychol Rep 2009;105:747–58.
37. Ramos M, Ripoll J, Estrades T, et al. Effectiveness of intensive
group and individual interventions for smoking cessation in primary
health care settings: a randomized trial. BMC Public Health
2010;10:89.
38. Torrecilla García M, Barrueco Ferrero M, Maderuelo Fernández J,
et al. [Tobacco detoxication at a primary care clinic: efficacy of
medical counseling, minimal intervention and nicotine replacement
therapy at the one-year follow-up]. Aten Primaria 2001;27:629–36.
39. Miller WR, Rollnick S. Motivational interviewing. New York:
Preparing people for change Guilford, 2002.
40. Prochaska JO, DiClemente CC. The transtheoretical approach.
Handb Psychother Integr 2005;2:147–71.
41. Becoña E, Vázquez FL. Does using relapse prevention increase the
efficacy of a program for smoking cessation? An empirical study.
Psychol Rep 1997;81:291–6.
42. Cene CW, Yanek LR, Moy TE, et al. Sustainability of a multiple risk
factor intervention on cardiovascular disease in high-risk African
American families. Ethn Dis 2008;18:169–75.
43. Wittchen HU, Hoch E, Klotsche J, et al. Smoking cessation in
primary care—a randomized controlled trial of bupropione, nicotine
replacements, CBT and a minimal intervention. Int J Methods
Psychiatr Res 2011;20:28–39.
44. Zhu SH, Stretch V, Balabanis M, et al. Telephone counseling for
smoking cessation: effects of single-session and multiple-session
interventions. J Consult Clin Psychol 1996;64:202–11.
45. Aveyard P, Begh R, Parsons A, et al. Brief opportunistic smoking
cessation interventions: a systematic review and meta-analysis to
compare advice to quit and offer of assistance. Addiction
2012;107:1066–73.
46. Lancaster T, Stead LF. Individual behavioural counselling for
smoking cessation. Cochrane Database Syst Rev 2005;(2):
CD001292.
47. Wu P, Wilson K, Dimoulas P, et al. Effectiveness of smoking
cessation therapies: a systematic review and meta-analysis.
BMC Public Health 2006;6:300.
48. Andersen S, Keller C, McGowan N. Smoking cessation: the state of
the science. The utility of the transtheoretical model in guiding
interventions in smoking cessation. Online J Knowl Synth Nurs
1999;6:9.
49. Cahill K, Lancaster T, Green N. Stage-based interventions for smoking
cessation. Cochrane Database Syst Rev. 2010;10:CD004492.
50. Riemsma RP, Pattenden J, Bridle C, et al. Systematic review of the
effectiveness of stage based interventions to promote smoking
cessation. BMJ 2003;326:1175–7.
51. Tobacco Cochrane Addiction Group. Glossary. 2014. http://tobacco.
ochrane.org7glossary (accessed 11 Dec 2014).
52. West R, Hajek P, Stead L. Outcome criteria in smoking cessation
trials: proposal for a common standard. Addiction
2005;100:299–303.
53. Society for Research on Nicotine and tobacco Europe.
SRNT-Europe chapter recommendations. Record keeping for
smoking cessation services. 2014. http://www.srnteurope.org/assets/
record-keeping-for-smoking-cessation-services.pdf. (accessed 11
Dec 2014).
16 Martín Cantera C, et al. BMJ Open 2015;5:e008807. doi:10.1136/bmjopen-2015-008807
Open Access
group.bmj.com on January 8, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
adults: a systematic review
to promote continuous smoking cessation in
interventions in primary healthcare settings 
Effectiveness of multicomponent
Pérez-Tortosa, Laura Díaz-Gete and Sílvia Granollers
Arias, Lourdes Clemente, Ramon Casas, Lydia Roig, Santiago 
Carlos Martín Cantera, Elisa Puigdomènech, Jose Luis Ballvé, Olga Lucía
doi: 10.1136/bmjopen-2015-008807
2015 5: BMJ Open 
 http://bmjopen.bmj.com/content/5/10/e008807
Updated information and services can be found at: 
These include:
Material
Supplementary
 807.DC1.html
http://bmjopen.bmj.com/content/suppl/2015/10/01/bmjopen-2015-008
Supplementary material can be found at: 
References
 #BIBLhttp://bmjopen.bmj.com/content/5/10/e008807
This article cites 44 articles, 9 of which you can access for free at: 
Open Access
http://creativecommons.org/licenses/by-nc/4.0/non-commercial. See: 
provided the original work is properly cited and the use is
non-commercially, and license their derivative works on different terms, 
permits others to distribute, remix, adapt, build upon this work
Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
This is an Open Access article distributed in accordance with the Creative
service
Email alerting
box at the top right corner of the online article. 
Receive free email alerts when new articles cite this article. Sign up in the
Collections
Topic Articles on similar topics can be found in the following collections 
 (169)Smoking and tobacco
 (1340)Public health
 (393)General practice / Family practice
Notes
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on January 8, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
